SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636050-15-000017
Filing Date
2015-11-02
Accepted
2015-11-02 16:31:25
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a9301510q.htm 10-Q 647683
2 EXHIBIT 31.1 exhibit311.htm EX-31.1 9401
3 EXHIBIT 31.2 exhibit312.htm EX-31.2 9504
4 EXHIBIT 32.1 exhibit321.htm EX-32.1 5502
5 EXHIBIT 32.2 exhibit322.htm EX-32.2 5564
  Complete submission text file 0001636050-15-000017.txt   2419288

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT axon-20150930.xml EX-101.INS 199665
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axon-20150930.xsd EX-101.SCH 27614
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axon-20150930_cal.xml EX-101.CAL 34202
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axon-20150930_def.xml EX-101.DEF 113841
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axon-20150930_lab.xml EX-101.LAB 348330
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axon-20150930_pre.xml EX-101.PRE 189655
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37418 | Film No.: 151191005
SIC: 2834 Pharmaceutical Preparations